Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mattern

Showing results (101-110 of 162) with videos related to

Pageof 17
Sort By:
Forensic Science International|September 2, 1998
Postmortem distribution of dihydrocodeine and metabolites in a fatal case of dihydrocodeine intoxicationG Skopp, K Klinder, L Pötsch, et al.
Biochemical Society Transactions|September 17, 2008
Strategies for the identification of novel inhibitors of deubiquitinating enzymesSeth J Goldenberg, Jeffrey L McDermott, Tauseef R Butt, et al.
Zeitschrift Fur Gerontologie Und Geriatrie|May 1, 1996
[Sudden fatalities in mechanically restrained patients]I Pedal, R Mattern, R Reibold, et al.
Biochemistry|June 19, 1984
Changes in deoxyribonucleic acid linking number due to treatment of mammalian cells with the intercalating agent 4'-(9-acridinylamino)methanesulfon-m-anisidideY Pommier, M R Mattern, R E Schwartz, et al.
Biochemical Pharmacology|December 1, 1984
Absence of a requirement for long-range DNA torsional strain in the production of protein-associated DNA strand breaks in isolated mammalian cell nuclei by the DNA intercalating agent 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA)Y Pommier, L A Zwelling, R E Schwartz, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|April 1, 1991
Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cellsR D Woessner, M R Mattern, C K Mirabelli, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Elevated topoisomerase II activity and altered chromatin in nitrogen mustard-resistant human cellsK B Tan, M R Mattern, R A Boyce, et al.
Organic Letters|December 12, 2001
The first naturally occurring Tie2 kinase inhibitorB N Zhou, R K Johnson, M R Mattern, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 18, 2008
Driving-related risks and impact of methylphenidate treatment on driving in adults with attention-deficit/hyperactivity disorder (ADHD)E Sobanski, D Sabljic, B Alm, et al.
Journal of the National Cancer Institute|November 15, 1989
Nonproductive rearrangement of DNA topoisomerase I and II genes: correlation with resistance to topoisomerase inhibitorsK B Tan, M R Mattern, W K Eng, et al.
Pageof 17

Showing results (101-110 of 162) with videos related to

Sort By:
Pageof 17
Forensic Science International|September 2, 1998
Postmortem distribution of dihydrocodeine and metabolites in a fatal case of dihydrocodeine intoxicationG Skopp, K Klinder, L Pötsch, et al.
Biochemical Society Transactions|September 17, 2008
Strategies for the identification of novel inhibitors of deubiquitinating enzymesSeth J Goldenberg, Jeffrey L McDermott, Tauseef R Butt, et al.
Zeitschrift Fur Gerontologie Und Geriatrie|May 1, 1996
[Sudden fatalities in mechanically restrained patients]I Pedal, R Mattern, R Reibold, et al.
Biochemistry|June 19, 1984
Changes in deoxyribonucleic acid linking number due to treatment of mammalian cells with the intercalating agent 4'-(9-acridinylamino)methanesulfon-m-anisidideY Pommier, M R Mattern, R E Schwartz, et al.
Biochemical Pharmacology|December 1, 1984
Absence of a requirement for long-range DNA torsional strain in the production of protein-associated DNA strand breaks in isolated mammalian cell nuclei by the DNA intercalating agent 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA)Y Pommier, L A Zwelling, R E Schwartz, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|April 1, 1991
Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cellsR D Woessner, M R Mattern, C K Mirabelli, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Elevated topoisomerase II activity and altered chromatin in nitrogen mustard-resistant human cellsK B Tan, M R Mattern, R A Boyce, et al.
Organic Letters|December 12, 2001
The first naturally occurring Tie2 kinase inhibitorB N Zhou, R K Johnson, M R Mattern, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 18, 2008
Driving-related risks and impact of methylphenidate treatment on driving in adults with attention-deficit/hyperactivity disorder (ADHD)E Sobanski, D Sabljic, B Alm, et al.
Journal of the National Cancer Institute|November 15, 1989
Nonproductive rearrangement of DNA topoisomerase I and II genes: correlation with resistance to topoisomerase inhibitorsK B Tan, M R Mattern, W K Eng, et al.
Pageof 17